OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-12-31-accounts

Trustees Professor Michael Professor Michael Milward President 2023 2023
Dr Ra/an
Nansi
President 2022
Professor Mark Ide Immediate Past President Resigned 31 December 2022
Professor Wendy Turner Honorary Secretary
Dr lan Dunn Honorary Treasurer
Professor
Philip
Preshaw President Elect 2024 Appointed 1 January 2023
Professor Nicola West President Elect 2025
Professor Francis Hughes Senior Vice President Resigned 31 December 2022
Professor Gerry Linden Senior Vice President Appointed 1 January 2023
Dr Alexander
Pollard
Honorary Editor
Dr Viren Vithlani Commercial Liaison Officer
Charity number 265815
Princl pa I address P0 Box261
Liverpool
L25 6WP
Independent examiner Alison Whalley FCA
Azets
Carlton House
Bradford
BD1 4NS
Bankers CAF Bank Ltd
25 Kings
Hill Avenue
Kings
Hill
West Mailling
Kent
ME194JQ
Bank ofScotland
33 Old Broad Street
London
BX2 1LB

Page
Trustees
report
1-9
Independent
examiner's
report 10
Statement
of financial
activities
Balance sheet 12
Notes to the accounts 13-23

PRIZE Award
Audit award
F500
No award
Sir Wilfred Fish Research Prize
Vitor Neves E1,000
"Glucose metabolism
medicine. "
modulation in periodontal disease prevention as a form ofpreventive
S stematic Review Prize
Varkha
Rattu
E1,000
"Prevalence ofstable and successfully treated periodontitis subjects and incidence ofsubsequent
"
tooth loss within supportive periodontal care: A systematic review and meta-analyses.
BSPClinical Fellowshl award Up to E4,000
Hong Jin Tan per award
Frank Ashle Under raduate Prize
E500
Kate McNelly
BSPResearch Grant Up to F5,000
Joshua Jackson per award
Poster Prize
Clinical:
Chaitanya
Joshi
f500 each
Research:
Annabel
Simpson

Date Type of
Event
Title Presenter
Time to take periodontitis
seriously: economic &societal
20 Jan Webinar costs and how to implement
the steps ofcare in real
Prof lain Chapple
world NHS practice
Avoidance
of Doubt - the S3guidelines
and phased
10Feb Webinar treatment
approach
to periodontal
care within the NHS
Dr Shazad Saleem
dental contract
10 Mar Webinar Approaching/implementing
behaviour
change
in treating
periodontal
disease
in practice
Dr Christoph
Ramseier
26 Apr Webinar Management
of peri-implantitis
a pragmatic
approach
Prof Andreas
Stavropoulos
17 May Webinar Pre-prosthetic
surgery
- Enabling
optimal
restorations
Prof Moritz Kebschull
Minimally
invasive
non-surgical
periodontal
therapy
9 Jun Webinar practical approaches
and protocols to ultrasonic
Dr Devan
Raindi
debridement
22nd Jun Masterclass Peri-Implantitis
Masterclass —Diagnosis and Treatment
Modalities
Prof Nikos Donos
12Jul Webinar Instrumentation
selection and advanced
techniques
for
sub gingival
PMPR
Ms Claire McCarthy
13-15hOct Conference BSPConference 2022 Dr Rajah Nansi
1 Nov Webinar Supportive
Periodontal
Care
—Practical
implementation
ofstep 4 of the S3guidelines
Dr Viren Vithlani
16 Nov Webinar The Bernese Concept for the Treatment
of Single and
Multiple
Mandibular
Recessions
Prof Anton Sculean

Unrestricted Restricted Total Unrestricted Restricted Total
funds funds funds funds
2022 2022 2021 2021 2021
Notes 6 6 f 8 6
Income from:
Donations
and legacies
3 1,000 1,000 1,000 6,000 7,000
Charitable
activities
4 366,919 85,000 451,919 394,626 50,000 444,626
Investments 5 3,361 3,361 861 861
Total income 371,280 85,000 456,280 396,487 56,000 452,487
~E«dlt
Charitable
activities
6 319,305 32,587 351,892 324,490 33,737 358,227
Net Income for the year/
Net movement
ln funds
51,975 52,413 104,388 71,997 22,263 94,260
Fund balances at 1
January 2022 561,065 75,895 636,960 489,068 53,632 542,700
Fund balances at 31
December 2022 613,040 128,308 741,348 561,065 75,895 636,960

2022 2021
Notes 6 8
Fixed assets
Tangible assets 705
Current assets
Debtors 12 35,236 28,048
Cash at bank and in hand 736,832 660,528
772,068 688,576
Creditors: amounts falling due within
one year 13 (31,425) (51,616)
Net current assets 740,643 636,960
Total assets less current liabilities 741,348 636,960
Income funds
Restricted funds 15 128,308 75,895
Unrestricted
funds
Designated
funds
16 371,920 371,825
General
unrestricted
funds 241,120 189,240
613,040 561,065
741,348 636,960

Charitable Charitable
Income Income
2022 2021
8 6
Subscriptions 201,535 195,617
Partnership agreements 85,OOO 50,000
Conferences 144,064 189,425
Educational courses and webinars 18,000 6,530
Leaflet sales 3,320 3,054
451,919 444,626
Analysis
by fund
Unrestricted funds 366,919 394,626
Restricted funds 85,000 50,000
451,919 444,626

Unrestricted Unrestricted
funds funds
2022 2021
6 6
Interest receivable 3,361 861

2022 2021
6 6
Journal - paper 9,512 10,729
Journal
- electronic
37,519 39,085
Conference costs 89,143 149,464
Event management fees 32,817 23,907
Awards
and prizes
12,331 10,682
Educational
initiative
26,265 33,737
Educational
courses
and webinars 19,793 9,042
BSPEvents/Non
BSPEvents
7,314
Donations
and sponsorship
1,030
235,724 276,646
Share ofsupport costs (see note 7) 105,600 76,50e
Share of governance costs (see note 7) 10,568 5,073
351,892 358,227
Analysis
by fund
Unrestricted
funds
319,305 324,490
Restricted
funds
32,587 33,737
351,892 358,227

7 Supportcosts
Support Governance 2022 Support Governance 2021
costs costs costs costs
f f 6 f
Depreciation 503 503
Legal fees 1,056 1,056
Admin
travel
268 268 110 110
Business Management
fees 54,402 54,402 44,358 44,358
Office costs 13,939 13,939 9,347 9,347
Insurance 668 668 610 610
Sundry 562 562 1,001 1,001
Irrecoverable
VAT
25,209 25,209 13,583 13,583
Computer
and
website 2,801 2,801 2,012 2,012
Worldpay
and
Bank
charges 5,343 5,343 2,178 2,178
Accountancy 849 849 3,309 3,309
Cost oftrustees meetings 525 525 41 41
Independent
examination
4,500 4,500 4,500 4,500
Indemnity
insurance
881 881 456 456
Trustees and council
members
expenses
4,662 4,662 76 76
105,600 10,568 116,168 76,508 5,073 81,581
Analysed
between
Charitable
activities
105,600 10,568 116,168 76,508 5,073 81,581

11 Tangible fixed assets Tangible fixed assets Tangible fixed assets
Fixtures and fittings
6
Cost
At 1 January 2022 4,250
Additions 1,208
At 31 December 2022 5,458
Depreciation and Impairment
At 1 January 2022 4,250
Depreciation charged in the year 503
At 31 December 2022 4,753
Carrying
amount
At 31 December 2022 705
12 Debtors
2022 2021
Amounts
falling due
within one year: 8 8
Trade debtors 24,000
Other debtors 1,817 1,608
Prepayments and accrued income 33,419 2,440
35,236 28,048
13 Creditors: amounts falling due within one year
2022 2021
Notes 6 f
Deferred income 14 21,560 33,027
Trade creditors 5,115 5,255
Accruals 4,750 13,334
31,425 51,616

2022 2021
E E
Other deferred income 21,560 33,027
Deferred income is included in the financial statements as follows:
2022 2021
E E
Brought forward 33,027 178,135
Amount released to income (33,027) (175,316)
Amount deferred in year 21,560 33,027
Refunded (2,819)
Carried forward 21,560 33,027

Movement in funds Movement in funds
Balance at Incoming Resources Balance at Incoming Resources Balance at
1 January 2021 resources expended1 January 2022 resources expended 31 December
2022
E F E E E
Partnership
Agreements 53,632 50,000 (33,737) 69,895 85,000 (32,337) 122,558
Patient
Forum 6,000 6,000 (250) 5,750
53,632 56,000 (33,737) 75,895 85,000 (32,587) 128,308

Balance at Transfers Balance at Transfers Balance at
1 January
2021
1 January
2022
31 December
2022
E E
Contingency Fund 141,670 284 141,954 95 142,049
EP8 2015 Legacy 175,000 175,000 175,000
EP9 2018 Legacy 54,871 54,871 54,871
371,541 284 371,825 95 371,920

Funds
Balance at1 Income Expenditure Transfers Balance at 31
January
2022
December
2022
E E E E E
Restricted funds 75,895 85,000 (32,587) 128,308
Designated funds 371,825 95 371,920
General funds 189,240 371,280 (319,305) (95) 241,120
636,960 456,280 (351,892) 741,348
Funds prior year
Balance at 1 Income Expenditure Transfers Balance at 31
January
2021
December
2021
E E E E E
Restricted funds 53,632 56,000 (33,737) 75,895
Designated funds 371,541 284 371,825
General funds 117,527 396,487 (324,490) (284) 189,240
542,700 452,487 (358,227) 636,960
m
0
DI
O
4I O
(D
CD
O
(D
Ot
(D
CO
(D
CD
(O
(D
lD 4l ID ID
m 0 OI
CO
CO
OI
DI
ID0t CO CO
CI
l3
8
0
CII0
OI
4(
N
m
m
m
CV
o
O O
Ct(3 CD
CO
Ot
CO
4l
I- D
t-
CV
O
Ol
O
MI-Z
CII-
00
m
C
00
Ol
olO
OI
4l O
Dt
I(O
O
Dt
CO
III
Ct
CI
D
(D
0
OI
CVO
Ol
4l CO
O
CO
CO
O
CO
CO
+ Dt
Dt
CIZ Ct
It"
00
0I-Z0
CI0
CI
UJDZI-z0
O
V)I-Z
UJ
UI m
C
CtG
Ol
O
Ol
4l ID
O
ID
O
O
PI
Kl
UJ m
0 I-c(
M
O
LLI
CI
Dt
'O
C
C
Ct
(0
CI
Cl
Xl
O0
V)z
V)I-
Kl
ZI-
OZ
z
UJZI-0I-
N
UJI-0z
UI
CI
CI
UJ
8
(A
lft
Ol
(DCID
Ilt
(0C
E
Ct0
tDD
(0
N0t
0
C
t0
Ol
l3
C
Cl
lD
Ct
C(0
tfl
S
Ot
fD
Ct
g
(0
'at
Ot
Im
(0
ID
Zlt0
N
S
(0
C
m
0